Filings

ASX Filings

Date	Description
February 26, 2020	Opthea Half Year Report and Accounts
February 18, 2020	Opthea to Present at the 9th Annual SVB Leerink Global Healthcare Conference
January 16, 2020	Ceasing to be a substantial holder
January 9, 2020	Becoming a substantial holder
January 7, 2020	Opthea Completes Recruitment in Phase 2a Clinical Trial of OPT-302 for Diabetic Macular Edema

There are no SEC filings available.

Data provided by Kaleidoscope.